Practical guidance on pharmaceutical CSV, QA, data integrity, and regulatory compliance - written and reviewed by Mohammad Awawdeh.
Subscribe via RSSBrowse by topic
Start with the service that matches your objective, then use its connected guides to plan the work.
PHARPRO completed clean room air balance execution, testing and documentation at a client site in Damascus, Syria - part of an active regional validation project.
Read article →A practical guide to pharmaceutical water system validation - Purified Water and WFI, covering DQ/IQ/OQ/PQ, the three-phase sampling plan and ongoing monitoring.
Read article →A practical Validation 4.0 roadmap connecting risk-based validation, digital workflows, data integrity, automation and human quality oversight.
Read guide & explore PHARPRO DVS →How pharmaceutical companies can implement digital validation workflows for URS, risk assessment, IQ/OQ/PQ, RTM, review and electronic approval.
Read guide & explore PHARPRO DVS →Explore PHARPRO DVS for connected URS, risk assessment, IQ/OQ/PQ, RTM, audit trails, controlled review and AI-assisted validation drafting.
Read guide & explore PHARPRO DVS →A governance guide for using AI in pharmaceutical validation while maintaining human approval, traceability, data integrity and risk-based oversight.
Read guide & explore PHARPRO DVS →Explore practical AI use cases in pharma across validation, quality, manufacturing and knowledge work, with governance and human oversight controls.
Read guide & explore PHARPRO DVS →PHARPRO thermal mapping services for pharmaceutical warehouses, cold rooms, freezers, stability chambers and temperature-controlled areas across MENA.
Read the service guide →PHARPRO turnkey validation projects covering VMP, CQV, CSV, utilities, equipment, process, cleaning, protocols, execution and approved handover.
Read the service guide →PHARPRO now provides cleanroom environmental monitoring: air change rate, non-viable particles, temperature, humidity, mapping and differential pressure testing.
Read the service guide →How to design a defensible cold-room study: risk-based logger positions, empty and loaded testing, door-opening challenges, alarms and final reporting.
Read article →A lifecycle guide to URS, DQ, FAT/SAT, IQ/OQ/PQ, deviations, release, continued verification and risk-based requalification.
Read article →Connect cleanroom use and contamination risk to HEPA integrity, airflow, pressure, recovery, classification and performance qualification.
Read article →Practical controls for governance, ALCOA+, hybrid records, audit trails, access, review, investigations and sustainable remediation.
Read article →Two-day comprehensive GMP training: 12 modules covering regulatory frameworks, QMS, data integrity (ALCOA+), equipment qualification, CAPA, change control & inspection readiness. Certificate of Completion. Online & in-person. Last cohort before Q4 inspection season. Limited to 30 seats.
Read article & register →PHARPRO CSV Training rescheduled from 5–6 August to 27 & 28 October 2026. Two-day intensive: GAMP 5 Second Edition risk model, IQ/OQ/PQ protocol writing, data integrity (ALCOA+), FDA 21 CFR Part 11, EU GMP Annex 11 & a full case study. Certificate of Completion. Online & in-person. Limited to 20 seats.
Read article & register →PHARPRO announces a new partnership covering end-to-end drug registration across Jordan (JFDA), Syria, Lebanon, and GCC markets — dossier preparation, regulatory submissions, and post-approval maintenance. Free initial consultation available.
Read announcement & enquire →PHARPRO's new pharma marketing partnership delivers brand positioning, HCP outreach, KOL engagement, and compliant promotional materials for pharmaceutical companies entering or growing in the Jordanian market. Enquire for a proposal.
Read announcement & enquire →How pharma teams can move from disconnected Word and Excel CSV work to controlled digital validation software for URS, risk assessment, IQ/OQ/PQ, RTM, electronic approvals and audit trails — aligned with GAMP 5, FDA 21 CFR Part 11 and EU GMP Annex 11.
Read the digitalization guide →Model software cost, internal effort, rework and review time using your own baseline. Includes a transparent framework for pilot measurement instead of unsupported savings claims.
Build the ROI case →What GSDP is, what JFDA requires for pharmaceutical storage and distribution facilities in Jordan, and how PHARPRO helps companies achieve and maintain compliance — including temperature monitoring, GDP documentation, and inspection readiness.
Read article →A risk-based migration plan for moving validation records, requirements traceability, review and approvals out of disconnected office files.
Read the migration guide →PHARPRO's structured gap assessment covers FDA 21 CFR Part 11, EU GMP Annex 11, and GAMP 5. Deliverable: written gap report with risk-prioritised remediation roadmap. Free initial consultation — no commitment.
Request free assessment →PHARPRO DVS is AI validation lifecycle software with 30 document builders from URS to VSR - compared to manual Word/Excel approaches, reviewed for FDA 21 CFR Part 11 and EU GMP Annex 11 compliance.
Read article →50 questions your QA team should answer before any FDA, EU GMP, or national authority inspection. Print-ready and free.
Get the checklist →DVS-PQR workflow launched, validation work completed, thermal mapping training expanded to Pakistan, and PHARPRO project activity summarized for June 2026.
Read the full update →What ISPE GAMP 5 Second Edition means for your validation programme - new three-category risk model, critical thinking principles, cloud system guidance, and what to update in your existing documentation.
Read article →A practical checklist covering every major area EU GMP inspectors assess - supplier qualification, validation documentation, audit trails, access controls, change control, and periodic review.
Read article →How to build an effective CAPA system - root cause analysis, corrective actions, effectiveness checks, and what FDA and EU GMP inspectors expect to see in your CAPA records.
Read article →Received an FDA Warning Letter? How to structure your response, address observations correctly, avoid common mistakes, and restore regulatory standing step by step.
Read article →A practical guide to qualifying pharma suppliers - the risk-based approach, audit checklist, quality agreements, and ongoing monitoring requirements under EU GMP Chapter 5 and FDA 21 CFR.
Read article →How to validate SaaS and cloud-hosted GxP systems - GAMP 5 category classification, vendor qualification, data integrity controls, and change management for vendor-initiated updates.
Read article →How to prepare your pharmaceutical site for an FDA, EU GMP, or national authority inspection - documentation review, data integrity checks, staff briefing, and mock audits.
Read article →What a VMP must contain, who approves it, how it links to your validation programme - and the common gaps regulators find in Validation Master Plans during EU GMP and FDA inspections.
Read article →System-level and functional risk assessment for computerised systems - GAMP 5 categories, risk-based testing, and how to document your risk rationale in an audit-ready format.
Read article →How to build and maintain a training matrix, what records regulators require, and the most common GMP training findings that lead to inspection observations - and how to avoid them.
Read article →Electronic records, audit trails, electronic signatures, and access controls - exactly what 21 CFR Part 11 requires, and the seven compliance gaps that most commonly generate FDA warning letters.
Read article →Complete knowledge base
Use these connected topic paths to move from a regulatory question to an implementation-ready plan.
Mohammad answers practical compliance questions - no sales pitch, just straight answers.
Get a Free Assessment